Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Equity Ratio (2022 - 2025)

Historic Equity Ratio for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to 0.42.

  • Orchestra BioMed Holdings' Equity Ratio fell 3199.16% to 0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42, marking a year-over-year decrease of 3199.16%. This contributed to the annual value of 0.43 for FY2024, which is 3945.64% down from last year.
  • Orchestra BioMed Holdings' Equity Ratio amounted to 0.42 in Q3 2025, which was down 3199.16% from 0.01 recorded in Q2 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Equity Ratio ranged from a high of 0.73 in Q1 2023 and a low of 0.09 during Q3 2022
  • Moreover, its 4-year median value for Equity Ratio was 0.55 (2022), whereas its average is 0.42.
  • Its Equity Ratio has fluctuated over the past 5 years, first soared by 279957.67% in 2023, then plummeted by 9887.0% in 2025.
  • Quarter analysis of 4 years shows Orchestra BioMed Holdings' Equity Ratio stood at 0.55 in 2022, then skyrocketed by 30.01% to 0.71 in 2023, then crashed by 39.46% to 0.43 in 2024, then dropped by 3.55% to 0.42 in 2025.
  • Its Equity Ratio was 0.42 in Q3 2025, compared to 0.01 in Q2 2025 and 0.29 in Q1 2025.